These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34625635)

  • 1. MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity.
    Boumiza S; Chahed K; Tabka Z; Jacob MP; Norel X; Ozen G
    Sci Rep; 2021 Oct; 11(1):20052. PubMed ID: 34625635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
    Głowińska-Olszewska B; Urban M
    Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis.
    Martinho FC; Teixeira FF; Cardoso FG; Ferreira NS; Nascimento GG; Carvalho CA; Valera MC
    J Endod; 2016 Jul; 42(7):1082-8. PubMed ID: 27188765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
    Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
    J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.
    Gomes VA; Vieira CS; Jacob-Ferreira AL; Belo VA; Soares GM; Fernandes JB; Ferriani RA; Tanus-Santos JE
    Mol Cell Biochem; 2011 Jul; 353(1-2):251-7. PubMed ID: 21437624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome.
    Bieniaś B; Sikora P
    Medicine (Baltimore); 2018 Feb; 97(8):e9964. PubMed ID: 29465592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients.
    Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
    Acta Ophthalmol; 2015 Mar; 93(2):165-71. PubMed ID: 25312247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation increases MMP levels via PGE
    Ozen G; Boumiza S; Deschildre C; Topal G; Longrois D; Jakobsson PJ; Michel JB; Jacob MP; Chahed K; Norel X
    Int J Obes (Lond); 2019 Sep; 43(9):1724-1734. PubMed ID: 30349011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.
    Shin YH; Kim KE; Lee YJ; Nam JH; Hong YM; Shin HJ
    Korean J Pediatr; 2014 Dec; 57(12):526-32. PubMed ID: 25653686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis.
    Zakiyanov O; Chocová Z; Hrušková Z; Hladinová Z; Kalousová M; Maličková K; Vachek J; Wurmová P; Kříha V; Zima T; Tesař V
    Folia Biol (Praha); 2019; 65(5-6):227-236. PubMed ID: 32362306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction.
    Barton AK; Shety T; Bondzio A; Einspanier R; Gehlen H
    BMC Vet Res; 2016 Dec; 12(1):282. PubMed ID: 27938355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B; Głowińska B; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
    Bonnema DD; Webb CS; Pennington WR; Stroud RE; Leonardi AE; Clark LL; McClure CD; Finklea L; Spinale FG; Zile MR
    J Card Fail; 2007 Sep; 13(7):530-40. PubMed ID: 17826643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.